Georgetown University

This study tests a new type of radiation therapy for men with low to intermediate risk prostate cancer. The treatment uses MRI scans to give a higher radiation dose directly to the tumor while lowering the dose to the rest of the prostate, aiming to control the cancer with fewer …

This study tests whether adding a cancer vaccine (NY-ESO-1) to standard immunotherapy can prevent the cancer from becoming resistant to treatment. It involves 24 women with advanced ovarian cancer that has stopped responding to platinum chemotherapy. The goal is to see if this co…

This study tests a personalized approach to hormone therapy for men with metastatic hormone-sensitive prostate cancer. The goal is to reduce treatment intensity for lower-risk patients to minimize side effects while still controlling the cancer. About 108 participants will receiv…

This early-stage study tests whether resveratrol (JOTROL) is safe and tolerable for people with Parkinson's disease. About 30 participants will receive either a low dose, high dose, or placebo daily for 3 months. The goal is to check for side effects and measure how the drug beha…

This study looks at the best way to help prostate cancer survivors learn about and get genetic testing for inherited cancer risks. About 500 participants will be randomly assigned to a digital guide, a printed guide, or standard care. Researchers will track who requests testing a…